Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines - Exclusive Production. (Process: 25410.008181/2025-88)
Deadline: 02 Jul 2026
Posting Date: 23 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143803652
Document Ref. No.: 91151/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Medicines - Exclusive Production. (PROCESS: 25410.008181/2025-88) UASG code: 250052 Notice from: 06/22/2026 from 09:00 to 16:00 Proposal Delivery: from 06/22/2026 at 09:00 ABYRATERONE ACETATE, CONCENTRATION 250 MG Quantity: 104880 ALTEPLASE, CONCENTRATION 50 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION + DILUENT Quantity: 39 ALTEPLASE, CONCENTRATION 50 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION + DILUENT Quantity: 11 BRENTUXIMAB VEDOTIN, CONCENTRATION 50 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 250 CARMUSTINE, DOSAGE 100 MG, INJECTABLE USE Quantity: 155 CYCLOPHOSPHAMIDE, CONCENTRATION 1 G, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 5919 CYCLOPHOSPHAMIDE, COMPOSITION 50 MG Quantity: 22524 CYCLOSPORINE, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 927 CLADRIBIN, CONCENTRATION 1 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 48 DAUNORUBICIN, DOSAGE 20 MG, INJECTABLE PRESENTATION Quantity: 844 FLUDROCORTISONE ACETATE, DOSAGE 0.1 MG Quantity: 10850 IMMUNOGLOBULIN HUMAN ANTITHYMOCYTES, RABBIT TYPE, CONCENTRATION 25 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 1240 PLERIXAFOR, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 21 RASBURICASE, CONCENTRATION 1.5 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 1413 BEVACIZUMAB, CONCENTRATION 25 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 400 BEVACIZUMAB, CONCENTRATION 25 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 121 VINORELBINE, COMPOSITION SALT TARTARATE, CONCENTRATION 20 MG Quantity: 1122 VINORELBINE, COMPOSITION SALT TARTARATE, CONCENTRATION 30 MG Quantity: 1398 G1 Quantity :
Documents
Tender Notice